▶ 調査レポート

世界のチロシンヒドロキシラーゼ欠乏薬市場:市場規模・現状・予測

• 英文タイトル:Global Tyrosine Hydroxylase Deficiency Drugs Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界のチロシンヒドロキシラーゼ欠乏薬市場:市場規模・現状・予測 / Global Tyrosine Hydroxylase Deficiency Drugs Market Size, Status and Forecast 2019-2025 / QYR9N8151資料のイメージです。• レポートコード:QYR9N8151
• 出版社/出版日:QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、99ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当資料は、チロシンヒドロキシラーゼ欠乏薬のグローバル市場について調査・分析したレポートで、種類別(トリヘキシフェニジル、アマンタジン、その他)、用途別(病院、診療所、診断センター、その他)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・チロシンヒドロキシラーゼ欠乏薬の世界市場規模
・主要企業別市場シェア
・チロシンヒドロキシラーゼ欠乏薬の世界市場規模:種類別(トリヘキシフェニジル、アマンタジン、その他)
・チロシンヒドロキシラーゼ欠乏薬の世界市場規模:用途別(病院、診療所、診断センター、その他)
・チロシンヒドロキシラーゼ欠乏薬のアメリカ市場規模(種類別、用途別)
・チロシンヒドロキシラーゼ欠乏薬のヨーロッパ市場規模(種類別、用途別)
・チロシンヒドロキシラーゼ欠乏薬の中国市場規模(種類別、用途別)
・チロシンヒドロキシラーゼ欠乏薬の日本市場規模(種類別、用途別)
・チロシンヒドロキシラーゼ欠乏薬の東南アジア市場規模(種類別、用途別)
・チロシンヒドロキシラーゼ欠乏薬のインド市場規模(種類別、用途別)
・チロシンヒドロキシラーゼ欠乏薬の中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・チロシンヒドロキシラーゼ欠乏薬の世界市場予測(2019年-2025年)
・チロシンヒドロキシラーゼ欠乏薬の地域別市場予測(2019年-2025年)
...

The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the Tyrosine Hydroxylase Deficiency, and it varies from patient to patient. The most common symptoms include the uncoordinated or clumsy manner of walking (abnormal gait) and dystonia. In mild and severe cases patients may have neurological disorders.Asia Pacific is expected to be the fastest growing market whose growth is attributed to a huge demand for diagnostic tests and increasing focus on early diagnosis and treatment of heart diseases.
In 2018, the global Tyrosine Hydroxylase Deficiency Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Tyrosine Hydroxylase Deficiency Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tyrosine Hydroxylase Deficiency Drugs development in United States, Europe and China.

The key players covered in this study
Pfizer
GlaxoSmithKline
Eli Lilly
Abbott
Taj Pharmaceuticals

Market segment by Type, the product can be split into
Trihexyphenidyl
Amantadine
Others

Market segment by Application, split into
Hospitals
Clinics
Diagnostic Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Tyrosine Hydroxylase Deficiency Drugs status, future forecast, growth opportunity, key market and key players.
To present the Tyrosine Hydroxylase Deficiency Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Tyrosine Hydroxylase Deficiency Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Tyrosine Hydroxylase Deficiency Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Trihexyphenidyl
1.4.3 Amantadine
1.4.4 Others
1.5 Market by Application
1.5.1 Global Tyrosine Hydroxylase Deficiency Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Diagnostic Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Tyrosine Hydroxylase Deficiency Drugs Market Size
2.2 Tyrosine Hydroxylase Deficiency Drugs Growth Trends by Regions
2.2.1 Tyrosine Hydroxylase Deficiency Drugs Market Size by Regions (2014-2025)
2.2.2 Tyrosine Hydroxylase Deficiency Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Tyrosine Hydroxylase Deficiency Drugs Market Size by Manufacturers
3.1.1 Global Tyrosine Hydroxylase Deficiency Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Tyrosine Hydroxylase Deficiency Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Tyrosine Hydroxylase Deficiency Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Tyrosine Hydroxylase Deficiency Drugs Key Players Head office and Area Served
3.3 Key Players Tyrosine Hydroxylase Deficiency Drugs Product/Solution/Service
3.4 Date of Enter into Tyrosine Hydroxylase Deficiency Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Tyrosine Hydroxylase Deficiency Drugs Market Size by Type (2014-2019)
4.2 Global Tyrosine Hydroxylase Deficiency Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Tyrosine Hydroxylase Deficiency Drugs Market Size (2014-2019)
5.2 Tyrosine Hydroxylase Deficiency Drugs Key Players in United States
5.3 United States Tyrosine Hydroxylase Deficiency Drugs Market Size by Type
5.4 United States Tyrosine Hydroxylase Deficiency Drugs Market Size by Application

6 Europe
6.1 Europe Tyrosine Hydroxylase Deficiency Drugs Market Size (2014-2019)
6.2 Tyrosine Hydroxylase Deficiency Drugs Key Players in Europe
6.3 Europe Tyrosine Hydroxylase Deficiency Drugs Market Size by Type
6.4 Europe Tyrosine Hydroxylase Deficiency Drugs Market Size by Application

7 China
7.1 China Tyrosine Hydroxylase Deficiency Drugs Market Size (2014-2019)
7.2 Tyrosine Hydroxylase Deficiency Drugs Key Players in China
7.3 China Tyrosine Hydroxylase Deficiency Drugs Market Size by Type
7.4 China Tyrosine Hydroxylase Deficiency Drugs Market Size by Application

8 Japan
8.1 Japan Tyrosine Hydroxylase Deficiency Drugs Market Size (2014-2019)
8.2 Tyrosine Hydroxylase Deficiency Drugs Key Players in Japan
8.3 Japan Tyrosine Hydroxylase Deficiency Drugs Market Size by Type
8.4 Japan Tyrosine Hydroxylase Deficiency Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Tyrosine Hydroxylase Deficiency Drugs Market Size (2014-2019)
9.2 Tyrosine Hydroxylase Deficiency Drugs Key Players in Southeast Asia
9.3 Southeast Asia Tyrosine Hydroxylase Deficiency Drugs Market Size by Type
9.4 Southeast Asia Tyrosine Hydroxylase Deficiency Drugs Market Size by Application

10 India
10.1 India Tyrosine Hydroxylase Deficiency Drugs Market Size (2014-2019)
10.2 Tyrosine Hydroxylase Deficiency Drugs Key Players in India
10.3 India Tyrosine Hydroxylase Deficiency Drugs Market Size by Type
10.4 India Tyrosine Hydroxylase Deficiency Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Tyrosine Hydroxylase Deficiency Drugs Market Size (2014-2019)
11.2 Tyrosine Hydroxylase Deficiency Drugs Key Players in Central & South America
11.3 Central & South America Tyrosine Hydroxylase Deficiency Drugs Market Size by Type
11.4 Central & South America Tyrosine Hydroxylase Deficiency Drugs Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Tyrosine Hydroxylase Deficiency Drugs Introduction
12.1.4 Pfizer Revenue in Tyrosine Hydroxylase Deficiency Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Tyrosine Hydroxylase Deficiency Drugs Introduction
12.2.4 GlaxoSmithKline Revenue in Tyrosine Hydroxylase Deficiency Drugs Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Tyrosine Hydroxylase Deficiency Drugs Introduction
12.3.4 Eli Lilly Revenue in Tyrosine Hydroxylase Deficiency Drugs Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 Abbott
12.4.1 Abbott Company Details
12.4.2 Company Description and Business Overview
12.4.3 Tyrosine Hydroxylase Deficiency Drugs Introduction
12.4.4 Abbott Revenue in Tyrosine Hydroxylase Deficiency Drugs Business (2014-2019)
12.4.5 Abbott Recent Development
12.5 Taj Pharmaceuticals
12.5.1 Taj Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Tyrosine Hydroxylase Deficiency Drugs Introduction
12.5.4 Taj Pharmaceuticals Revenue in Tyrosine Hydroxylase Deficiency Drugs Business (2014-2019)
12.5.5 Taj Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Tyrosine Hydroxylase Deficiency Drugs Key Market Segments
Table Key Players Tyrosine Hydroxylase Deficiency Drugs Covered
Table Global Tyrosine Hydroxylase Deficiency Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Tyrosine Hydroxylase Deficiency Drugs Market Size Market Share by Type 2014-2025
Figure Trihexyphenidyl Figures
Table Key Players of Trihexyphenidyl
Figure Amantadine Figures
Table Key Players of Amantadine
Figure Others Figures
Table Key Players of Others
Table Global Tyrosine Hydroxylase Deficiency Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Diagnostic Centers Case Studies
Figure Others Case Studies
Figure Tyrosine Hydroxylase Deficiency Drugs Report Years Considered
Table Global Tyrosine Hydroxylase Deficiency Drugs Market Size 2014-2025 (Million US$)
Figure Global Tyrosine Hydroxylase Deficiency Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Tyrosine Hydroxylase Deficiency Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Tyrosine Hydroxylase Deficiency Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Tyrosine Hydroxylase Deficiency Drugs Market Share by Regions 2014-2019
Figure Global Tyrosine Hydroxylase Deficiency Drugs Market Share by Regions 2014-2019
Figure Global Tyrosine Hydroxylase Deficiency Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Tyrosine Hydroxylase Deficiency Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Tyrosine Hydroxylase Deficiency Drugs Market Share by Manufacturers (2014-2019)
Figure Global Tyrosine Hydroxylase Deficiency Drugs Market Share by Manufacturers in 2018
Table Global Tyrosine Hydroxylase Deficiency Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Tyrosine Hydroxylase Deficiency Drugs Product/Solution/Service
Table Date of Enter into Tyrosine Hydroxylase Deficiency Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Tyrosine Hydroxylase Deficiency Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Tyrosine Hydroxylase Deficiency Drugs Market Size Share by Type (2014-2019)
Figure Global Tyrosine Hydroxylase Deficiency Drugs Market Size Market Share by Type (2014-2019)
Table Global Tyrosine Hydroxylase Deficiency Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Tyrosine Hydroxylase Deficiency Drugs Market Size Share by Application (2014-2019)
Figure Global Tyrosine Hydroxylase Deficiency Drugs Market Size Market Share by Application (2014-2019)
Figure Global Tyrosine Hydroxylase Deficiency Drugs Revenue Market Share by Application in 2018
Figure United States Tyrosine Hydroxylase Deficiency Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Tyrosine Hydroxylase Deficiency Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Tyrosine Hydroxylase Deficiency Drugs Market Share (2018-2019)
Table United States Tyrosine Hydroxylase Deficiency Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Tyrosine Hydroxylase Deficiency Drugs Market Share by Type (2014-2019)
Table United States Tyrosine Hydroxylase Deficiency Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Tyrosine Hydroxylase Deficiency Drugs Market Share by Application (2014-2019)
Figure Europe Tyrosine Hydroxylase Deficiency Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Tyrosine Hydroxylase Deficiency Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Tyrosine Hydroxylase Deficiency Drugs Market Share (2018-2019)
Table Europe Tyrosine Hydroxylase Deficiency Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Tyrosine Hydroxylase Deficiency Drugs Market Share by Type (2014-2019)
Table Europe Tyrosine Hydroxylase Deficiency Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Tyrosine Hydroxylase Deficiency Drugs Market Share by Application (2014-2019)
Figure China Tyrosine Hydroxylase Deficiency Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Tyrosine Hydroxylase Deficiency Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Tyrosine Hydroxylase Deficiency Drugs Market Share (2018-2019)
Table China Tyrosine Hydroxylase Deficiency Drugs Market Size by Type (2014-20189) (Million US$)
Table China Tyrosine Hydroxylase Deficiency Drugs Market Share by Type (2014-2019)
Table China Tyrosine Hydroxylase Deficiency Drugs Market Size by Application (2014-2019) (Million US$)
Table China Tyrosine Hydroxylase Deficiency Drugs Market Share by Application (2014-2019)
Figure Japan Tyrosine Hydroxylase Deficiency Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Tyrosine Hydroxylase Deficiency Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Tyrosine Hydroxylase Deficiency Drugs Market Share (2018-2019)
Table Japan Tyrosine Hydroxylase Deficiency Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Tyrosine Hydroxylase Deficiency Drugs Market Share by Type (2014-2019)
Table Japan Tyrosine Hydroxylase Deficiency Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Tyrosine Hydroxylase Deficiency Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Tyrosine Hydroxylase Deficiency Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Tyrosine Hydroxylase Deficiency Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Tyrosine Hydroxylase Deficiency Drugs Market Share (2018-2019)
Table Southeast Asia Tyrosine Hydroxylase Deficiency Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Tyrosine Hydroxylase Deficiency Drugs Market Share by Type (2014-2019)
Table Southeast Asia Tyrosine Hydroxylase Deficiency Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Tyrosine Hydroxylase Deficiency Drugs Market Share by Application (2014-2019)
Figure India Tyrosine Hydroxylase Deficiency Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Tyrosine Hydroxylase Deficiency Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Tyrosine Hydroxylase Deficiency Drugs Market Share (2018-2019)
Table India Tyrosine Hydroxylase Deficiency Drugs Market Size by Type (2014-2019) (Million US$)
Table India Tyrosine Hydroxylase Deficiency Drugs Market Share by Type (2014-2019)
Table India Tyrosine Hydroxylase Deficiency Drugs Market Size by Application (2014-2019) (Million US$)
Table India Tyrosine Hydroxylase Deficiency Drugs Market Share by Application (2014-2019)
Figure Central & South America Tyrosine Hydroxylase Deficiency Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Tyrosine Hydroxylase Deficiency Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Tyrosine Hydroxylase Deficiency Drugs Market Share (2018-2019)
Table Central & South America Tyrosine Hydroxylase Deficiency Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Tyrosine Hydroxylase Deficiency Drugs Market Share by Type (2014-2019)
Table Central & South America Tyrosine Hydroxylase Deficiency Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Tyrosine Hydroxylase Deficiency Drugs Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Tyrosine Hydroxylase Deficiency Drugs Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Tyrosine Hydroxylase Deficiency Drugs Business (2014-2019)
Table Pfizer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Tyrosine Hydroxylase Deficiency Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Tyrosine Hydroxylase Deficiency Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Tyrosine Hydroxylase Deficiency Drugs Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Tyrosine Hydroxylase Deficiency Drugs Business (2014-2019)
Table Eli Lilly Recent Development
Table Abbott Company Details
Table Abbott Revenue in Tyrosine Hydroxylase Deficiency Drugs Business (2014-2019)(Million US$)
Figure Abbott Revenue Growth Rate in Tyrosine Hydroxylase Deficiency Drugs Business (2014-2019)
Table Abbott Recent Development
Table Taj Pharmaceuticals Company Details
Table Taj Pharmaceuticals Revenue in Tyrosine Hydroxylase Deficiency Drugs Business (2014-2019)(Million US$)
Figure Taj Pharmaceuticals Revenue Growth Rate in Tyrosine Hydroxylase Deficiency Drugs Business (2014-2019)
Table Taj Pharmaceuticals Recent Development
Table Global Tyrosine Hydroxylase Deficiency Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Tyrosine Hydroxylase Deficiency Drugs Market Size Share by Regions (2019-2025)
Figure Global Tyrosine Hydroxylase Deficiency Drugs Market Size Share by Regions in 2025
Figure United States Tyrosine Hydroxylase Deficiency Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Tyrosine Hydroxylase Deficiency Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Tyrosine Hydroxylase Deficiency Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Tyrosine Hydroxylase Deficiency Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Tyrosine Hydroxylase Deficiency Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Tyrosine Hydroxylase Deficiency Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Tyrosine Hydroxylase Deficiency Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Tyrosine Hydroxylase Deficiency Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Tyrosine Hydroxylase Deficiency Drugs Market Size by Product (2019-2025)
Figure Global Tyrosine Hydroxylase Deficiency Drugs Market Size by Product in 2025
Table Global Tyrosine Hydroxylase Deficiency Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Tyrosine Hydroxylase Deficiency Drugs Market Size by Application (2019-2025)
Figure Global Tyrosine Hydroxylase Deficiency Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources